CD4 and rheumatoid arthritis: Several biomarkers reflecting systemic inflammation (e.g., TNFRSF11A, PTX3, CTSL1, and CD4) were increased in patients with RA, which may reflect a link between RA-associated inflammation and diastolic dysfunction (7).